Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
09/2005
09/22/2005WO2005087931A1 Modified oncolytic viruses
09/22/2005WO2005087288A1 Medicinal preparation for angiogenesis
09/22/2005WO2005087271A1 Compositions comprising cells and magnetic materials for targeted delivery
09/22/2005WO2005087269A1 Method of inhibiting tumor proliferation
09/22/2005WO2005087241A1 Infection-controlling agent for livestock, poultry or fish
09/22/2005WO2005087240A1 Antidiarrheal agent for livestock and poultry
09/22/2005WO2005087239A1 Tissue repair with multipotent cells
09/22/2005WO2005087022A1 Food composition having antistress effect
09/22/2005WO2005086781A2 Regulatory t cells and their use in immunotherapy and suppression of autoimmune responses
09/22/2005WO2005068498A3 Human therapeutic cells secreting nerve growth factor
09/22/2005WO2005067962A3 Composition derived from milk goat comprising growth factors and oligosaccharides
09/22/2005WO2005052139A3 Method of inducing memory b cell development and terminal differentiation
09/22/2005WO2005049072A3 Therapeutic cancer vaccine with fragments of trag-3
09/22/2005WO2005021734A3 Generation of hematopoietic chimerism and induction of central tolerance
09/22/2005WO2005018580A3 Anti-cancer virus desensitization method
09/22/2005WO2005000327A3 Use of bacilli bacteria in order to produce a composition for the prevention of vertebral compression syndrome in salmonids
09/22/2005WO2003092471A3 Cell-seeded extracellular matrix grafts
09/22/2005WO2003065997A3 Anti-infarction molecules
09/22/2005US20050209177 Combined use of genes that block oncogenic cell signalling pathways and chemotherapeutic and or radiotherapeutic agents
09/22/2005US20050208655 Blood cells having modified antigenicity
09/22/2005US20050208654 Process for producing T lymphocytes
09/22/2005US20050208653 Pancreatic progenitor cell culture for use in prevention and treatment of infection, diabetes and liver disorders
09/22/2005US20050208649 Reversibly sealable dewar vessel comprising insulating material for transfer of viable mammalian cells or organs
09/22/2005US20050208638 Process for preparing bioactive protein-enriched whey products
09/22/2005US20050208552 Corpuscles of Stannius protein, stanniocalcin
09/22/2005US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
09/22/2005US20050208150 Compositions for elastrogenesis and connective tissue treatment
09/22/2005US20050208147 Isolation of bivittoside D from sea cucumber and activity thereof
09/22/2005US20050208138 Injection of a biocompatible polymer, polysaccharide or polyamino acid, a cross-linker, and therapeutic agent into tumor; hydrogel formed in the tumor retains the therapeutic agent; drug delivery method; sustained releasing the biodrug
09/22/2005US20050208079 Glucan-based vaccines
09/22/2005US20050208064 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
09/22/2005US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin
09/22/2005US20050208036 Graft versus host disease; administering lymphocytes ,hematopoietic stem cells
09/22/2005US20050208035 Nutritional composition for treating an immune condition
09/22/2005US20050208034 Pau D' Arco, La Pacho, tabebuia heptaphylla, lactobacillus acidophilus, bifidobacterium bifidum, bifidobacterium longum, streptococcus thermophilus, lactobacillus bulgaricus, lactobacillus bulgaricus, lactobacillus paracasei, allium sativum or concentrated Garlic bulb; ingested orally
09/22/2005US20050208033 Induction of cell apoptosis of colon cancer; anticancer agent is 5 fluoro-uracil; bacterial strain is in a live or irradiated form
09/22/2005US20050208030 Myocardial grafts and cellular compositions useful for same
09/22/2005US20050208029 Method of forming pancreatic beta cells from mesenchymal cells
09/22/2005US20050208028 Nutrient Medium for maintaining neural cells in injured nervous system
09/22/2005US20050208026 Tissue engineered uterus
09/22/2005US20050208025 Enhancement of hematopoietic stem cell survival
09/22/2005US20050208024 Treating cancer in humans; obtain human, administer antitumor agent, evaluate tumor response to antitumor agents
09/22/2005US20050205498 Preparation of a cell concentrate from a physiological solution
09/22/2005DE10135432B4 Verfahren zur Qualitätsverbesserung von verflüssigtem Moorbrei A method for improving the quality of liquefied Moorbrei
09/22/2005CA2581424A1 Methods for generating insulin-producing cells
09/22/2005CA2560209A1 Tissue repair
09/22/2005CA2560046A1 Methods for suppressing tumor proliferation
09/22/2005CA2559813A1 Antidiarrheal agent for livestock and poultry
09/22/2005CA2559055A1 Modified oncolytic viruses
09/22/2005CA2558777A1 Regulatory t cells and their use in immunotherapy and suppression of autoimmune responses
09/21/2005EP1577391A1 Neutrokine alpha
09/21/2005EP1577381A1 Tumor/B-cell hybrid cells and uses thereof
09/21/2005EP1576957A1 Tissue repair using pluripotent cells
09/21/2005EP1576143A2 Virus-like particles, methods of preparation, and immonogenic compositions
09/21/2005EP1576120A2 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens
09/21/2005EP1576117A2 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells
09/21/2005EP1576091A2 Adult human olfactory stem cell
09/21/2005EP1576089A2 Expansion of renewable stem cell populations
09/21/2005EP1575976A2 Methods and compositions for therapeutic use of rna interference
09/21/2005EP1575643A2 Directly injectable formulations which provide enhanced cryoprotection of cell products
09/21/2005EP1575602A2 Methods for treating cancer using porimin as a target
09/21/2005EP1575573A2 Agents and methods for treatment of disease by oligosaccharide targeting agents
09/21/2005EP1575572A2 Collagen biofabric and methods of preparation and use therefor
09/21/2005EP1575551A1 Nutritional supplement composition and method
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575503A2 Compositions and methods for treating and preventing infection
09/21/2005EP1575479A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
09/21/2005EP1575419A2 Forming iron nitrosyl hemoglobin
09/21/2005EP1575379A1 Nutritional compositions
09/21/2005EP1575364A2 Methods and compositions using compounds from fetal cells and tissues to improve condition of skin
09/21/2005EP1534819A4 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
09/21/2005EP1461037A4 Beverage treated with nicotine
09/21/2005EP1307246B1 Biomaterial including animal corneal tissue
09/21/2005EP1263936B1 Altered strain of the modified vaccinia virus ankara (mva)
09/21/2005EP1192256B1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP1056544B1 Continuous magnetic separation of components from a mixture
09/21/2005EP1027371B1 Process for the production of highly viral safe thrombin for forming fibrin glue from a pool of human plasma
09/21/2005EP0996459B1 Use of exendins and agonists thereof for the reduction of food intake
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005CN1671851A Flavivirus vaccine delivery system
09/21/2005CN1671836A Primarily cultured adipocytes for gene therapy
09/21/2005CN1671835A A method for the establishment of a pluripotent human blastocyst-derived stem cell line
09/21/2005CN1671733A Compositions and methods for WT1 specific immunotherapy
09/21/2005CN1671729A Control sequences of the human Corin gene
09/21/2005CN1671403A Dioxin elimination promoter
09/21/2005CN1671402A Allomone repulsive and kairomone attractive compositions for controlling arachnids
09/21/2005CN1670215A Method for preparing transgenic bombyx mori and its application in pharmacy
09/21/2005CN1670188A Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
09/21/2005CN1670186A Pseudomonas aeruginosa mannose sensitive haemagglutination pilus strain
09/21/2005CN1670183A Microbial L. rhamnosus GM-020 and its use for treating obesity
09/21/2005CN1669453A Health product containing camellia chrysantha
09/21/2005CN1219876C Streptomycete albogriseus spnov
09/21/2005CN1219543C Chinese medicine for invigorating liver, kidney and spleen, nourishing blood, tranquilizing mind relaxing bowels and the prepn process of the Chinese medicine prepn
09/21/2005CN1219541C Chinese medicine for invigorating vital energy and benefiting kidney and the preparation process of the granule
09/21/2005CN1219537C Chinese medicine for treating leucocythemia and its preparation method
09/21/2005CN1219536C Lithiasis treating Chinese medicine preparation
09/21/2005CN1219533C Medicine for treating chronic layngopharyngitis and preparation process thereof
09/21/2005CN1219532C Chinese herbal medicine for treating gynecology disease and its preparing method
1 ... 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 ... 1259